Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “interleukin”

134 pharma patents match "interleukin" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 134
Index total 30,257
Page 6 / 6

Quick answer

This filtered view shows 134 pharmaceutical patents matching "interleukin" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

134 results for “interleukin” · 30,257 patents in full index Clear search

  1. US 6258948

    Inhibitors of Interleukin-1.beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2001 · Expires Jul 5, 2021

    expired

  2. US 6251878

    Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotective tamarind oligosaccharides

    The Board of Regents of the University of Texas System · Granted Jun 26, 2001 · Expires Jun 21, 2021

    expired

  3. US 6239268

    Interleukin-1 type 3 receptors

    Neurocrine Biosciences, Inc. · Granted May 29, 2001 · Expires May 24, 2021

    expired

  4. US 6204261

    Inhibitors of interleukin-1.beta. Converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 20, 2001 · Expires Mar 15, 2021

    expired

  5. US 6191269

    Selective induction of cell death by delivery of amino-terminal interleukin-1-.alpha. pro-piece polypeptide

    The Regents of the University of California · Granted Feb 20, 2001 · Expires Feb 15, 2021

    expired

  6. US 6190656

    Immunologic enhancement with intermittent interleukin-2 therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 20, 2001 · Expires Feb 15, 2021

    expired

  7. US 6162790

    Inhibitors of interleukin-1.beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2000 · Expires Dec 14, 2020

    expired

  8. US 6162800

    N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2000 · Expires Dec 14, 2020

    expired

  9. US 6136787

    Interleukin 1.beta. protease and interleukin 1.beta. protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 24, 2000 · Expires Oct 19, 2020

    expired

  10. US 6121266

    Pyridazines as interleukin-1.beta. converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 19, 2000 · Expires Sep 14, 2020

    expired

  11. US 6103711

    Inhibitors of interleukin-1.beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Aug 15, 2000 · Expires Aug 10, 2020

    expired

  12. US 6083503

    Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 4, 2000 · Expires Jun 29, 2020

    expired

  13. US 6063371

    Pharmaceutical compositions comprising a soluble interleukin-4 receptor

    The United States of America as represented by the Secretary of the Army · Granted May 16, 2000 · Expires May 11, 2020

    expired

  14. US 6025147

    Inhibitors of interleukin-1 .beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 15, 2000 · Expires Feb 10, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.